{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Demyelination", "Herbal therapy", "Inflammation", "Multiple sclerosis", "Remyelination"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "30607330", "DateRevised": {"Year": "2020", "Month": "10", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "11", "Day": "29"}], "Language": ["eng"], "ELocationID": ["10.15171/apb.2018.066"], "Journal": {"ISSN": "2228-5881", "JournalIssue": {"Volume": "8", "Issue": "4", "PubDate": {"Year": "2018", "Month": "Nov"}}, "Title": "Advanced pharmaceutical bulletin", "ISOAbbreviation": "Adv Pharm Bull"}, "ArticleTitle": "A Review of Herbal Therapy in Multiple Sclerosis.", "Pagination": {"StartPage": "575", "EndPage": "590", "MedlinePgn": "575-590"}, "Abstract": {"AbstractText": ["Multiple sclerosis is a complex autoimmune disorder which characterized by demyelination and axonal loss in the central nervous system (CNS). Several evidences indicate that some new drugs and stem cell therapy have opened a new horizon for multiple sclerosis treatment, but current therapies are partially effective or not safe in the long term. Recently, herbal therapies represent a promising therapeutic approach for multiple sclerosis disease. Here, we consider the potential benefits of some herbal compounds on different aspects of multiple sclerosis disease. The medicinal plants and their derivatives; Ginkgo biloba, Zingiber officinale, Curcuma longa, Hypericum perforatum, Valeriana officinalis, Vaccinium macrocarpon, Nigella sativa,Piper methysticum, Crocus sativus, Panax ginseng, Boswellia papyrifera, Vitis vinifera, Gastrodia elata, Camellia sinensis, Oenothera biennis, MS14 and Cannabis sativa have been informed to have several therapeutic effects in MS patients."]}, "AuthorList": [{"Identifier": ["0000-0001-5479-1168"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Young Researchers and Elite Club, Behshahr Branch, Islamic Azad University, Behshahr, Iran."}], "LastName": "Mojaverrostami", "ForeName": "Sina", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anatomy & Cell Biology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran."}, {"Identifier": [], "Affiliation": "Cellular and Molecular Research Center, Department of Anatomy & Cell Biology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran."}], "LastName": "Bojnordi", "ForeName": "Maryam Nazm", "Initials": "MN"}, {"Identifier": ["0000-0002-5014-5166"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran."}], "LastName": "Ghasemi-Kasman", "ForeName": "Maryam", "Initials": "M"}, {"Identifier": ["0000-0002-8769-9912"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Sciences Research Center, School of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran."}], "LastName": "Ebrahimzadeh", "ForeName": "Mohammad Ali", "Initials": "MA"}, {"Identifier": ["0000-0002-2178-6503"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anatomy & Cell Biology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran."}, {"Identifier": [], "Affiliation": "Immunogenetic Research Center, Department of Anatomy & Cell Biology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran."}], "LastName": "Hamidabadi", "ForeName": "Hatef Ghasemi", "Initials": "HG"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Iran", "MedlineTA": "Adv Pharm Bull", "NlmUniqueID": "101578021", "ISSNLinking": "2228-5881"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Camina-Tato M, Fernandez M, Morcillo-Suarez C, Navarro A, Julia E, Edo MC. et al. Genetic association of CASP8 polymorphisms with primary progressive multiple sclerosis. J Neuroimmunol. 2010;222(1-2):70\u20135. doi: 10.1016/j.jneuroim.2010.03.003.", "ArticleIdList": ["10.1016/j.jneuroim.2010.03.003", "20363033"]}, {"Citation": "Hasan KM, Walimuni IS, Abid H, Datta S, Wolinsky JS, Narayana PA. Human brain atlas-based multimodal MRI analysis of volumetry, diffusimetry, relaxometry and lesion distribution in multiple sclerosis patients and healthy adult controls: Implications for understanding the pathogenesis of multiple sclerosis and consolidation of quantitative MRI results in MS. J Neurol Sci. 2012;313(1-2):99\u2013109. doi: 10.1016/j.jns.2011.09.015.", "ArticleIdList": ["10.1016/j.jns.2011.09.015", "PMC3254796", "21978603"]}, {"Citation": "Franklin RJ, Ffrench-Constant C. Remyelination in the CNS: From biology to therapy. Nat Rev Neurosci. 2008;9(11):839\u201355. doi: 10.1038/nrn2480.", "ArticleIdList": ["10.1038/nrn2480", "18931697"]}, {"Citation": "Fancy SP, Kotter MR, Harrington EP, Huang JK, Zhao C, Rowitch DH. et al. Overcoming remyelination failure in multiple sclerosis and other myelin disorders. Exp Neurol. 2010;225(1):18\u201323. doi: 10.1016/j.expneurol.2009.12.020.", "ArticleIdList": ["10.1016/j.expneurol.2009.12.020", "20044992"]}, {"Citation": "Franklin RJ, Kotter MR. The biology of CNS remyelination: The key to therapeutic advances. J Neurol. 2008;255 Suppl 1:19\u201325. doi: 10.1007/s00415-008-1004-6.", "ArticleIdList": ["10.1007/s00415-008-1004-6", "18317673"]}, {"Citation": "Fancy SP, Zhao C, Franklin RJ. Increased expression of Nkx2.2 and Olig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS. Mol Cell Neurosci. 2004;27(3):247\u201354. doi: 10.1016/j.mcn.2004.06.015.", "ArticleIdList": ["10.1016/j.mcn.2004.06.015", "15519240"]}, {"Citation": "Gensert JM, Goldman JE. Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron. 1997;19(1):197\u2013203. doi: 10.1016/S0896-6273(00)80359-1.", "ArticleIdList": ["10.1016/S0896-6273(00)80359-1", "9247275"]}, {"Citation": "Nazm Bojnordi M, Ghasemi HH, Akbari E. Remyelination after lysophosphatidyl choline-induced demyelination is stimulated by bone marrow stromal cell-derived oligoprogenitor cell transplantation. Cells Tissues Organs. 2014;200(5):300\u20136. doi: 10.1159/000437350.", "ArticleIdList": ["10.1159/000437350", "26372950"]}, {"Citation": "Bjartmar C, Trapp BD. Axonal and neuronal degeneration in multiple sclerosis: Mechanisms and functional consequences. Curr Opin Neurol. 2001;14(3):271\u20138. doi: 10.1097/00019052-200106000-00003.", "ArticleIdList": ["10.1097/00019052-200106000-00003", "11371748"]}, {"Citation": "Nazm Bojnordi M, Movahedin M, Tiraihi T, Javan M, Ghasemi Hamidabadi H. Oligoprogenitor cells derived from spermatogonia stem cells improve remyelination in demyelination model. Mol Biotechnol. 2014;56(5):387\u201393. doi: 10.1007/s12033-013-9722-0.", "ArticleIdList": ["10.1007/s12033-013-9722-0", "24282061"]}, {"Citation": "Pourabdolhossein F, Hamidabadi HG, Bojnordi MN, Mojaverrostami S. Stem cell therapy: A promising therapeutic approach for multiple sclerosis. In: Zagon IS, McLaughlin PJ, editors. Multiple sclerosis: Perspectives in treatment and pathogenesis. Brisbane (AU): Codon Publications; 2017. P. 85-108.", "ArticleIdList": ["29261262"]}, {"Citation": "Herberts CA, Kwa MS, Hermsen HP. Risk factors in the development of stem cell therapy. J Transl Med. 2011;9(1):29. doi: 10.1186/1479-5876-9-29.", "ArticleIdList": ["10.1186/1479-5876-9-29", "PMC3070641", "21418664"]}, {"Citation": "Sanganalmath SK, Bolli R. Cell therapy for heart failure: A comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ Res. 2013;113(6):810\u201334. doi: 10.1161/CIRCRESAHA.113.300219.", "ArticleIdList": ["10.1161/CIRCRESAHA.113.300219", "PMC3892665", "23989721"]}, {"Citation": "Kasare\u0142\u0142o K, Cudnoch-J\u0119drzejewska A, Cz\u0142onkowski A, Mirowska-Guzel D. Mechanism of action of three newly registered drugs for multiple sclerosis treatment. Pharmacol Rep. 2017;69(4):702\u20138. doi: 10.1016/j.pharep.2017.02.017.", "ArticleIdList": ["10.1016/j.pharep.2017.02.017", "28550802"]}, {"Citation": "Katsavos S, Anagnostouli M. Biomarkers in multiple sclerosis: An up-to-date overview. Mult Scler Int. 2013;2013:340508. doi: 10.1155/2013/340508.", "ArticleIdList": ["10.1155/2013/340508", "PMC3564381", "23401777"]}, {"Citation": "Salvetti M, Landsman D, Schwarz-Lam P, Comi G, Thompson AJ, Fox RJ. Progressive MS: From pathophysiology to drug discovery. Mult Scler. 2015;21(11):1376\u201384. doi: 10.1177/1352458515603802.", "ArticleIdList": ["10.1177/1352458515603802", "26362902"]}, {"Citation": "de Jong HJI, Kingwell E, Shirani A, Cohen Tervaert JW, Hupperts R, Zhao Y. et al. Evaluating the safety of \u03b2-interferons in MS: A series of nested case-control studies. Neurology. 2017;88(24):2310\u201320. doi: 10.1212/WNL.0000000000004037.", "ArticleIdList": ["10.1212/WNL.0000000000004037", "PMC5567323", "28500224"]}, {"Citation": "Kim S, Chang L, Weinstock-Guttman B, Gandhi S, Jakimovski D, Carl E. et al. Complementary and alternative medicine usage by multiple sclerosis patients: Results from a prospective clinical study. J Altern Complement Med. 2018;24(6):596\u2013602. doi: 10.1089/acm.2017.0268.", "ArticleIdList": ["10.1089/acm.2017.0268", "PMC6006417", "29498537"]}, {"Citation": "Dayapoglu N, Tan M. Use of complementary and alternative medicine among people with multiple sclerosis in eastern turkey. Neurology Asia. 2016;21(1):63\u201371."}, {"Citation": "Mikaili P, Mojaverrostami S, Moloudizargari M, Aghajanshakeri S. Pharmacological and therapeutic effects of mentha longifolia L. And its main constituent, menthol. Anc Sci Life. 2013;33(2):131\u20138. doi: 10.4103/0257-7941.139059.", "ArticleIdList": ["10.4103/0257-7941.139059", "PMC4171855", "25284948"]}, {"Citation": "Agyare C, Spiegler V, Asase A, Scholz M, Hempel G, Hensel A. An ethnopharmacological survey of medicinal plants traditionally used for cancer treatment in the Ashanti region, ghana. J Ethnopharmacol. 2018;212:137\u201352. doi: 10.1016/j.jep.2017.10.019.", "ArticleIdList": ["10.1016/j.jep.2017.10.019", "29066406"]}, {"Citation": "Dehghan-Shahreza F, Beladi-Mousavi SS, Rafieian-Kopaei M. Medicinal plants and diabetic kidney disease; an updated review on the recent findings. Immunopathol Persa. 2016;2(1):e04."}, {"Citation": "Mohajeri M, Sadeghizadeh M, Najafi F, Javan M. Polymerized nano-curcumin attenuates neurological symptoms in eae model of multiple sclerosis through down regulation of inflammatory and oxidative processes and enhancing neuroprotection and myelin repair. Neuropharmacology. 2015;99:156\u201367. doi: 10.1016/j.neuropharm.2015.07.013.", "ArticleIdList": ["10.1016/j.neuropharm.2015.07.013", "26211978"]}, {"Citation": "Piao Y, Liang X. Chinese medicine in diabetic peripheral neuropathy: Experimental research on nerve repair and regeneration. Evid Based Complement Alternat Med. 2012;2012:191632. doi: 10.1155/2012/191632.", "ArticleIdList": ["10.1155/2012/191632", "PMC3426291", "22927874"]}, {"Citation": "Kaplan M, Mutlu EA, Benson M, Fields JZ, Banan A, Keshavarzian A. Use of herbal preparations in the treatment of oxidant-mediated inflammatory disorders. Complement Ther Med. 2007;15(3):207\u201316. doi: 10.1016/j.ctim.2006.06.005.", "ArticleIdList": ["10.1016/j.ctim.2006.06.005", "17709066"]}, {"Citation": "Olsen SA. A review of complementary and alternative medicine (CAM) by people with multiple sclerosis. Occup Ther Int. 2009;16(1):57\u201370. doi: 10.1002/oti.266.", "ArticleIdList": ["10.1002/oti.266", "19222053"]}, {"Citation": "Miller RE. An investigation into the management of the spasticity experienced by some patients with multiple sclerosis using acupuncture based on traditional chinese medicine. Complement Ther Med. 1996;4(1):58\u201362. doi: 10.1016/S0965-2299(96)80058-6.", "ArticleIdList": ["10.1016/S0965-2299(96)80058-6"]}, {"Citation": "Song L, Zhou QH, Wang HL, Liao FJ, Hua L, Zhang HF. et al. Chinese herbal medicine adjunct therapy in patients with acute relapse of multiple sclerosis: A systematic review and meta-analysis. Complement Ther Med. 2017;31:71\u201381. doi: 10.1016/j.ctim.2017.02.004.", "ArticleIdList": ["10.1016/j.ctim.2017.02.004", "28434474"]}, {"Citation": "Claflin SB, van der Mei IAF, Taylor BV. Complementary and alternative treatments of multiple sclerosis: A review of the evidence from 2001 to 2016. J Neurol Neurosurg Psychiatry. 2018;89(1):34\u201341. doi: 10.1136/jnnp-2016-314490.", "ArticleIdList": ["10.1136/jnnp-2016-314490", "28768821"]}, {"Citation": "Beaubrun G, Gray GE. A review of herbal medicines for psychiatric disorders. Psychiatr Serv. 2000;51(9):1130\u20134. doi: 10.1176/appi.ps.51.9.1130.", "ArticleIdList": ["10.1176/appi.ps.51.9.1130", "10970915"]}, {"Citation": "Wesnes KA, Ward T, McGinty A, Petrini O. The memory enhancing effects of a ginkgo biloba/panax ginseng combination in healthy middle-aged volunteers. Psychopharmacology (Berl) 2000;152(4):353\u201361. doi: 10.1007/s002130000533.", "ArticleIdList": ["10.1007/s002130000533", "11140327"]}, {"Citation": "Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF. A placebo-controlled, double-blind, randomized trial of an extract of ginkgo biloba for dementia. JAMA. 1997;278(16):1327\u201332. doi: 10.1001/jama.1997.03550160047037.", "ArticleIdList": ["10.1001/jama.1997.03550160047037", "9343463"]}, {"Citation": "Venkatesan R, Ji E, Kim SY. Phytochemicals that regulate neurodegenerative disease by targeting neurotrophins: A comprehensive review. Biomed Res Int. 2015;2015:814068. doi: 10.1155/2015/814068.", "ArticleIdList": ["10.1155/2015/814068", "PMC4446472", "26075266"]}, {"Citation": "Johnson SK, Diamond BJ, Rausch S, Kaufman M, Shiflett SC, Graves L. The effect of Ginkgo biloba on functional measures in multiple sclerosis: A pilot randomized controlled trial. Explore (NY) 2006;2(1):19\u201324. doi: 10.1016/j.explore.2005.10.007.", "ArticleIdList": ["10.1016/j.explore.2005.10.007", "16781604"]}, {"Citation": "Braquet P, Esanu A, Buisine E, Hosford D, Broquet C, Koltai M. Recent progress in ginkgolide research. Med Res Rev. 1991;11(3):295\u2013355. doi: 10.1002/med.2610110303.", "ArticleIdList": ["10.1002/med.2610110303", "1647474"]}, {"Citation": "Yadav V, Bever C Jr, Bowen J, Bowling A, Weinstock-Guttman B, Cameron M. et al. Summary of evidence-based guideline: Complementary and alternative medicine in multiple sclerosis: report of the guideline development subcommittee of the American Academy Of Neurology. Neurology. 2014;82(12):1083\u201392. doi: 10.1212/WNL.0000000000000250.", "ArticleIdList": ["10.1212/WNL.0000000000000250", "PMC3962995", "24663230"]}, {"Citation": "Lovera J, Bagert B, Smoot K, Morris CD, Frank R, Bogardus K. et al. Ginkgo biloba for the improvement of cognitive performance in multiple sclerosis: A randomized, placebo-controlled trial. Mult Scler. 2007;13(3):376\u201385. doi: 10.1177/1352458506071213.", "ArticleIdList": ["10.1177/1352458506071213", "17439907"]}, {"Citation": "Haniadka R, Rajeev AG, Palatty PL, Arora R, Baliga MS. Zingiber officinale (ginger) as an anti-emetic in cancer chemotherapy: A review. J Altern Complement Med. 2012;18(5):440\u20134. doi: 10.1089/acm.2010.0737.", "ArticleIdList": ["10.1089/acm.2010.0737", "22540971"]}, {"Citation": "Palatty PL, Haniadka R, Valder B, Arora R, Baliga MS. Ginger in the prevention of nausea and vomiting: A review. Crit Rev Food Sci Nutr. 2013;53(7):659\u201369. doi: 10.1080/10408398.2011.553751.", "ArticleIdList": ["10.1080/10408398.2011.553751", "23638927"]}, {"Citation": "Surh YJ. Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: A short review. Food Chem Toxicol. 2002;40(8):1091\u20137. doi: 10.1016/S0278-6915(02)00037-6.", "ArticleIdList": ["10.1016/S0278-6915(02)00037-6", "12067569"]}, {"Citation": "Eguchi A, Murakami A, Ohigashi H. Novel bioassay system for evaluating anti-oxidative activities of food items: Use of basolateral media from differentiated Caco-2 cells. Free Radic Res. 2005;39(12):1367\u201375. doi: 10.1080/10715760500045624.", "ArticleIdList": ["10.1080/10715760500045624", "16298867"]}, {"Citation": "Haniadka R, Saldanha E, Sunita V, Palatty PL, Fayad R, Baliga MS. A review of the gastroprotective effects of ginger (Zingiber officinale Roscoe) Food Funct. 2013;4(6):845\u201355. doi: 10.1039/c3fo30337c.", "ArticleIdList": ["10.1039/c3fo30337c", "23612703"]}, {"Citation": "Jafarzadeh A, Mohammadi-Kordkhayli M, Ahangar-Parvin R, Azizi V, Khoramdel-Azad H, Shamsizadeh A. et al. Ginger extracts influence the expression of IL-27 and IL-33 in the central nervous system in experimental autoimmune encephalomyelitis and ameliorates the clinical symptoms of disease. J Neuroimmunol. 2014;276(1-2):80\u20138. doi: 10.1016/j.jneuroim.2014.08.614.", "ArticleIdList": ["10.1016/j.jneuroim.2014.08.614", "25175065"]}, {"Citation": "Ha SK, Moon E, Ju MS, Kim DH, Ryu JH, Oh MS. et al. 6-Shogaol, a ginger product, modulates neuroinflammation: A new approach to neuroprotection. Neuropharmacology. 2012;63(2):211\u201323. doi: 10.1016/j.neuropharm.2012.03.016.", "ArticleIdList": ["10.1016/j.neuropharm.2012.03.016", "22465818"]}, {"Citation": "Ali BH, Blunden G, Tanira MO, Nemmar A. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): A review of recent research. Food Chem Toxicol. 2008;46(2):409\u201320. doi: 10.1016/j.fct.2007.09.085.", "ArticleIdList": ["10.1016/j.fct.2007.09.085", "17950516"]}, {"Citation": "Ho SC, Chang KS, Lin CC. Anti-neuroinflammatory capacity of fresh ginger is attributed mainly to 10-gingerol. Food Chem. 2013;141(3):3183\u201391. doi: 10.1016/j.foodchem.2013.06.010.", "ArticleIdList": ["10.1016/j.foodchem.2013.06.010", "23871076"]}, {"Citation": "Amirghofran Z. Herbal medicines for immunosuppression. Iran J Allergy Asthma Immunol. 2012;11(2):111\u20139.", "ArticleIdList": ["22761185"]}, {"Citation": "Srimal R, Dhawan B. Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmacol. 1973;25(6):447\u201352. doi: 10.1111/j.2042-7158.1973.tb09131.x.", "ArticleIdList": ["10.1111/j.2042-7158.1973.tb09131.x", "4146582"]}, {"Citation": "Huang HC, Jan TR, Yeh SF. Inhibitory effect of curcumin, an anti-inflammatory agent, on vascular smooth muscle cell proliferation. Eur J Pharmacol. 1992;221(2-3):381\u20134. doi: 10.1016/0014-2999(92)90727-L.", "ArticleIdList": ["10.1016/0014-2999(92)90727-L", "1426014"]}, {"Citation": "Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer res. 2003;23(1A):363\u201398.", "ArticleIdList": ["12680238"]}, {"Citation": "Naidu KA, Thippeswamy NB. Inhibition of human low density lipoprotein oxidation by active principles from spices. Mol Cell Biochem. 2002;229(1-2):19\u201323.", "ArticleIdList": ["11936843"]}, {"Citation": "Xie L, Li XK, Takahara S. Curcumin has bright prospects for the treatment of multiple sclerosis. Int Immunopharmacol. 2011;11(3):323\u201330. doi: 10.1016/j.intimp.2010.08.013.", "ArticleIdList": ["10.1016/j.intimp.2010.08.013", "20828641"]}, {"Citation": "Xie L, Li XK, Funeshima-Fuji N, Kimura H, Matsumoto Y, Isaka Y. et al. Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production. Int Immunopharmacol. 2009;9(5):575\u201381. doi: 10.1016/j.intimp.2009.01.025.", "ArticleIdList": ["10.1016/j.intimp.2009.01.025", "19539560"]}, {"Citation": "Natarajan C, Bright JJ. Curcumin Inhibits Experimental Allergic Encephalomyelitis by Blocking IL-12 Signaling Through Janus Kinase-STAT Pathway in T Lymphocytes. J Immunol. 2002;168(12):6506\u201313. doi: 10.4049/jimmunol.168.12.6506.", "ArticleIdList": ["10.4049/jimmunol.168.12.6506", "12055272"]}, {"Citation": "Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: A component of tumeric (Curcuma longa) J Altern Complement Med. 2003;9(1):161\u20138. doi: 10.1089/107555303321223035.", "ArticleIdList": ["10.1089/107555303321223035", "12676044"]}, {"Citation": "Henderson L, Yue QY, Bergquist C, Gerden B, Arlett P. St John's wort (Hypericum perforatum): Drug interactions and clinical outcomes. Br J Clin Pharmacol. 2002;54(4):349\u201356. doi: 10.1046/j.1365-2125.2002.01683.x.", "ArticleIdList": ["10.1046/j.1365-2125.2002.01683.x", "PMC1874438", "12392581"]}, {"Citation": "Dost T, Ozkayran H, Gokalp F, Yenisey C, Birincioglu M. The effect of Hypericum perforatum (St. John\u2019s Wort) on experimental colitis in rat. Dig Dis Sci. 2009;54(6):1214\u201321. doi: 10.1007/s10620-008-0477-6.", "ArticleIdList": ["10.1007/s10620-008-0477-6", "18754092"]}, {"Citation": "Schempp CM, Kirkin V, Simon-Haarhaus B, Kersten A, Kiss J, Termeer CC. et al. Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis. Oncogene. 2002;21(8):1242\u201350. doi: 10.1038/sj.onc.1205190.", "ArticleIdList": ["10.1038/sj.onc.1205190", "11850844"]}, {"Citation": "Lu YH, Du CB, Liu JW, Hong W, Wei DZ. Neuroprotective effects of Hypericum perforatum on trauma induced by hydrogen peroxide in PC12 cells. Am J Chin Med. 2004;32(3):397\u2013405. doi: 10.1142/S0192415X04002053.", "ArticleIdList": ["10.1142/S0192415X04002053", "15344423"]}, {"Citation": "Werneke U, Horn O, Taylor DM. How effective is St. John's wort? The evidence revisited. J Clin Psychiatry. 2004;65(5):611\u20137. doi: 10.4088/jcp.v65n0504.", "ArticleIdList": ["10.4088/jcp.v65n0504", "15163246"]}, {"Citation": "Bowling AC. Complementary and alternative medicine in multiple sclerosis. Continuum (Minneap Minn) 2010;16(5 Multiple Sclerosis):78\u201389. doi: 10.1212/01.CON.0000389935.84660.a5.", "ArticleIdList": ["10.1212/01.CON.0000389935.84660.a5", "22810599"]}, {"Citation": "DerMarderosian A, Beutler JA. The Review of Natural Products. St Louis, MO: Facts and Comparisons; 2002."}, {"Citation": "Suzuki O, Katsumata Y, Oya M, Bladt S, Wagner H. Inhibition of monoamine oxidase by hypercin. Planta Med. 1984;50(3):272\u20134. doi: 10.1055/s-2007-969700.", "ArticleIdList": ["10.1055/s-2007-969700", "6484033"]}, {"Citation": "Chavez ML, Chavez PI. Saint John's wort. Hosp Pharm. 1997;32:1621\u201332."}, {"Citation": "Cervo L, Rozio M, Ekalle-Soppo CB, Guiso G, Morazzoni P, Caccia S. Role of hyperforin in the antidepressant-like activity of hypericum perforatum extracts. Psychopharmacology (Berl) 2002;164(4):423\u20138. doi: 10.1007/s00213-002-1229-5.", "ArticleIdList": ["10.1007/s00213-002-1229-5", "12457273"]}, {"Citation": "Zanoli P. Role of hyperforin in the pharmacological activities of St. John's wort. CNS Drug Rev. 2004;10(3):203\u201318. doi: 10.1111/j.1527-3458.2004.tb00022.x.", "ArticleIdList": ["10.1111/j.1527-3458.2004.tb00022.x", "PMC6741737", "15492771"]}, {"Citation": "Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D. St John's wort for depression--an overview and meta-analysis of randomised clinical trials. BMJ. 1996;313(7052):253\u20138. doi: 10.1136/bmj.313.7052.253.", "ArticleIdList": ["10.1136/bmj.313.7052.253", "PMC2351679", "8704532"]}, {"Citation": "LaFrance WC Jr, Lauterbach EC, Coffey CE, Salloway SP, Kaufer DI, Reeve A. et al. The use of herbal alternative medicines in neuropsychiatry. A report of the ANPA committee on research. J Neuropsychiatry Clin Neurosci. 2000;12(2):177\u201392. doi: 10.1176/jnp.12.2.177.", "ArticleIdList": ["10.1176/jnp.12.2.177", "11001596"]}, {"Citation": "Naziroglu M, Kutluhan S, \u00d6vey \u0130S, Aykur M, Yurekli VA. Modulation of oxidative stress, apoptosis, and calcium entry in leukocytes of patients with multiple sclerosis by hypericum perforatum. Nutr Neurosci. 2014;17(5):214\u201321. doi: 10.1179/1476830513Y.0000000083.", "ArticleIdList": ["10.1179/1476830513Y.0000000083", "24075078"]}, {"Citation": "Brown DJ. Herbal prescriptions for better health: Your everyday guide to prevention, treatment, and care. Rocklin, CA: Prima Publishing; 1996."}, {"Citation": "Hsu PP. Natural medicines comprehensive database. J Med Libr Assoc. 2002;90(1):114."}, {"Citation": "Fleming WE, Pollak CP. Sleep disorders in multiple sclerosis. Semin Neurol. 2005;25(1):64\u20138. doi: 10.1055/s-2005-867075.", "ArticleIdList": ["10.1055/s-2005-867075", "15798938"]}, {"Citation": "Barton DL, Atherton PJ, Bauer BA, Moore DF Jr, Mattar BI, LaVasseur BI. et al. The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5) J Support Oncol. 2011;9(1):24\u201331. doi: 10.1016/j.suponc.2010.12.008.", "ArticleIdList": ["10.1016/j.suponc.2010.12.008", "PMC3052692", "21399726"]}, {"Citation": "Willey LB, Mady SP, Cobaugh DJ, Wax PM. Valerian overdose: A case report. Vet Hum Toxicol. 1995;37(4):364\u20135.", "ArticleIdList": ["8540231"]}, {"Citation": "Dugoua JJ, Seely D, Perri D, Mills E, Koren G. Safety and efficacy of cranberry (vaccinium macrocarpon) during pregnancy and lactation. Can J Clin Pharmacol. 2008;15(1):e80\u20136.", "ArticleIdList": ["18204103"]}, {"Citation": "Lynch DM. Cranberry for prevention of urinary tract infections. Am Fam Physician. 2004;70(11):2175\u20137.", "ArticleIdList": ["15606066"]}, {"Citation": "Betts CD, D'Mellow MT, Fowler CJ. Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1993;56(3):245\u201350. doi: 10.1136/jnnp.56.3.245.", "ArticleIdList": ["10.1136/jnnp.56.3.245", "PMC1014855", "8459239"]}, {"Citation": "Guay DR. Cranberry and urinary tract infections. Drugs. 2009;69(7):775\u2013807. doi: 10.2165/00003495-200969070-00002.", "ArticleIdList": ["10.2165/00003495-200969070-00002", "19441868"]}, {"Citation": "Liu Y, Black MA, Caron L, Camesano TA. Role of cranberry juice on molecular-scale surface characteristics and adhesion behavior of escherichia coli. Biotechnol Bioeng. 2006;93(2):297\u2013305. doi: 10.1002/bit.20675.", "ArticleIdList": ["10.1002/bit.20675", "16142789"]}, {"Citation": "Schultz A. Efficacy of cranberry juice and ascorbic acid in acidifying the urine in multiple sclerosis subjects. J Community Health Nurs. 1984;1(3):159\u201369. doi: 10.1207/s15327655jchn0103_5.", "ArticleIdList": ["10.1207/s15327655jchn0103_5", "6569071"]}, {"Citation": "Gallien P, Amarenco G, Benoit N, Bonniaud V, Donz\u00e9 C, Kerdraon J. et al. Cranberry versus placebo in the prevention of urinary infections in multiple sclerosis: A multicenter, randomized, placebo-controlled, double-blind trial. Mult Scler. 2014;20(9):1252\u20139. doi: 10.1177/1352458513517592.", "ArticleIdList": ["10.1177/1352458513517592", "24402038"]}, {"Citation": "Khare CP. Encyclopedia of indian medicinal plants. New York: Springes-Verlag; 2004."}, {"Citation": "El-Dakhakhny M. Studies on the Egyptian Nigella sativa L. IV. Some pharmacological properties of the seeds' active principle in comparison to its dihydro compound and its polymer. Arzneimittelforschung. 1965;15(10):1227\u20139.", "ArticleIdList": ["4380349"]}, {"Citation": "Salem ML. Immunomodulatory and therapeutic properties of the Nigella sativa L. Seed. Int Immunopharmacol. 2005;5(13-14):1749\u201370. doi: 10.1016/j.intimp.2005.06.008.", "ArticleIdList": ["10.1016/j.intimp.2005.06.008", "16275613"]}, {"Citation": "Fahmy HM, Noor NA, Mohammed FF, Elsayed AA, Radwan NM. Nigella sativa as an anti-inflammatory and promising remyelinating agent in the cortex and hippocampus of experimental autoimmune encephalomyelitis-induced rats. J Basic Appl Zool. 2014;67(5):182\u201395. doi: 10.1016/j.jobaz.2014.08.005.", "ArticleIdList": ["10.1016/j.jobaz.2014.08.005"]}, {"Citation": "Ghosheh OA, Houdi AA, Crooks PA. High performance liquid chromatographic analysis of the pharmacologically active quinones and related compounds in the oil of the black seed (Nigella sativa L.) J Pharm Biomed Anal. 1999;19(5):757\u201362. doi: 10.1016/S0731-7085(98)00300-8.", "ArticleIdList": ["10.1016/S0731-7085(98)00300-8", "10698539"]}, {"Citation": "Noor NA, Fahmy HM, Mohammed FF, Elsayed AA, Radwan NM. Nigella sativa amliorates inflammation and demyelination in the experimental autoimmune encephalomyelitis-induced Wistar rats. Int J Clin Exp Pathol. 2015;8(6):6269\u201386.", "ArticleIdList": ["PMC4525838", "26261504"]}, {"Citation": "Mansour M, Tornhamre S. Inhibition of 5-lipoxygenase and leukotriene C4 synthase in human blood cells by thymoquinone. J Enzyme Inhib Med Chem. 2004;19(5):431\u20136. doi: 10.1080/14756360400002072.", "ArticleIdList": ["10.1080/14756360400002072", "15648658"]}, {"Citation": "Houghton PJ, Zarka R, de las Heras B, Hoult JR. Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med. 1995;61(1):33\u20136. doi: 10.1055/s-2006-957994.", "ArticleIdList": ["10.1055/s-2006-957994", "7700988"]}, {"Citation": "El-Dakhakhny M, Madi NJ, Lembert N, Ammon HP. Nigella sativa oil, nigellone and derived thymoquinone inhibit synthesis of 5-lipoxygenase products in polymorphonuclear leukocytes from rats. J Ethnopharmacol. 2002;81(2):161\u20134. doi: 10.1016/S0378-8741(02)00051-X.", "ArticleIdList": ["10.1016/S0378-8741(02)00051-X", "12065147"]}, {"Citation": "Williamson EM. Synergy and other interactions in phytomedicines. Phytomedicine. 2001;8(5):401\u20139. doi: 10.1078/0944-7113-00060.", "ArticleIdList": ["10.1078/0944-7113-00060", "11695885"]}, {"Citation": "Wheatley D. Stress-induced insomnia treated with kava and valerian: Singly and in combination. Hum Psychopharmacol. 2001;16(4):353\u20136. doi: 10.1002/hup.299.", "ArticleIdList": ["10.1002/hup.299", "12404572"]}, {"Citation": "Jussofie A, Schmiz A, Hiemke C. Kavapyrone enriched extract fromPiper methysticum as modulator of the GABA binding site in different regions of rat brain. Psychopharmacology. 1994;116(4):469\u201374. doi: 10.1007/BF02247480.", "ArticleIdList": ["10.1007/BF02247480", "7701051"]}, {"Citation": "Davies LP, Drew CA, Duffield P, Johnston GA, Jamieson DD. Kava pyrones and resin: Studies on GABAA, GABAB and benzodiazepine binding sites in rodent brain. Pharmacol Toxicol. 1992;71(2):120\u20136. doi: 10.1111/j.1600-0773.1992.tb00530.x.", "ArticleIdList": ["10.1111/j.1600-0773.1992.tb00530.x", "1332016"]}, {"Citation": "Bowling AC. Complementary and alternative medicine and multiple sclerosis. Demos Medical Publishing; 2006."}, {"Citation": "Volz HP, Kieser M. Kava-kava extract WS 1490 versus placebo in anxiety disorders--A randomized placebo-controlled 25-week outpatient trial. Pharmacopsychiatry. 1997;30(1):1\u20135. doi: 10.1055/s-2007-979474.", "ArticleIdList": ["10.1055/s-2007-979474", "9065962"]}, {"Citation": "Rios JL, Recio MC, Giner RM, Manez S. An update review of saffron and its active constituents. Phytother Res. 1998;10(3):189\u201393."}, {"Citation": "Hosseinzadeh H, Younesi HM. Petal and stigma extracts of crocus sativus L. Have antinociceptive and anti-inflammatory effects in mice. BMC Pharmacol. 2002;2:7. doi: 10.1186/1472-6882-4-12.", "ArticleIdList": ["10.1186/1472-6882-4-12", "PMC101384", "11914135"]}, {"Citation": "Khazdair MR, Boskabady MH, Hosseini M, Rezaee R, Tsatsakis AM. The effects of crocus sativus (saffron) and its constituents on nervous system: A review. Avicenna J Phytomed. 2015;5(5):376\u201391.", "ArticleIdList": ["PMC4599112", "26468457"]}, {"Citation": "Abdullaev Jafarova F, Caballero-Ortega H, Riveron-Negrete L, Pereda-Miranda R, Rivera-Luna R, Manuel Hernandez J. et al. In vitro evaluation of the chemopreventive potential of saffron. Rev Invest Clin. 2002;54(5):430\u20136.", "ArticleIdList": ["12587418"]}, {"Citation": "Akhondzadeh S, Fallah-Pour H, Afkham K, Jamshidi AH, Khalighi-Cigaroudi F. Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816] BMC Complement Altern Med. 2004;4(1):12. doi: 10.1186/1472-6882-4-12.", "ArticleIdList": ["10.1186/1472-6882-4-12", "PMC517724", "15341662"]}, {"Citation": "Ghazavi A, Mosayebi G, Salehi H, Abtahi H. Effect of Ethanol Extract of Saffron (Crocus sativus L.) on the Inhibition of Experimental Autoimmune Encephalomyelitis in C57bl/6 Mice. Pak J Biol Sci. 2009;12(9):690\u20135. doi: 10.3923/pjbs.2009.690.695.", "ArticleIdList": ["10.3923/pjbs.2009.690.695", "19634472"]}, {"Citation": "Ghaffari S, Hatami H, Dehghan G. The effect of ethanolic extract of saffron (Crocus sativus L.) on oxidative stress markers in the hippocampus of experimental models of MS. Med J Tabriz Univ Med Sci Health Serv. 2015;37(1):40\u20139."}, {"Citation": "Christensen T. Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses. Rev Med Virol. 2005;15(3):179\u2013211. doi: 10.1002/rmv.465.", "ArticleIdList": ["10.1002/rmv.465", "15782388"]}, {"Citation": "Antony JM, Van Marle G, Opii W, Butterfield DA, Mallet F, Yong VW. et al. Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nat Neurosci. 2004;7(10):1088\u201395. doi: 10.1038/nn1319.", "ArticleIdList": ["10.1038/nn1319", "15452578"]}, {"Citation": "Barnett MH, Prineas JW. Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion. Ann Neurol. 2004;55(4):458\u201368. doi: 10.1002/ana.20016.", "ArticleIdList": ["10.1002/ana.20016", "15048884"]}, {"Citation": "Schmidt M, Betti G, Hensel A. Saffron in phytotherapy: Pharmacology and clinical uses. Wien Med Wochenschr. 2007;157(13-14):315\u20139. doi: 10.1007/s10354-007-0428-4.", "ArticleIdList": ["10.1007/s10354-007-0428-4", "17704979"]}, {"Citation": "Baker JT, Borris RP, Cart\u00e9 B, Cordell GA, Soejarto DD, Cragg GM. et al. Natural product drug discovery and development: New perspectives on international collaboration. J Nat Prod. 1995;58(9):1325\u201357. doi: 10.1021/np50123a003.", "ArticleIdList": ["10.1021/np50123a003", "7494142"]}, {"Citation": "Choi KT. Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C A Meyer. Acta Pharmacol Sin. 2008;29(9):1109\u201318. doi: 10.1111/j.1745-7254.2008.00869.x.", "ArticleIdList": ["10.1111/j.1745-7254.2008.00869.x", "18718180"]}, {"Citation": "Kim MH, Lee YC, Choi SY, Cho CW, Rho J, Lee KW. The changes of ginsenoside patterns in red ginseng processed by organic Acid impregnation pretreatment. J Ginseng Res. 2011;35(4):497\u2013503. doi: 10.5142/jgr.2011.35.4.497.", "ArticleIdList": ["10.5142/jgr.2011.35.4.497", "PMC3659558", "23717097"]}, {"Citation": "Yuan CS, Wang CZ, Wicks SM, Qi LW. Chemical and pharmacological studies of saponins with a focus on american ginseng. J Ginseng Res. 2010;34(3):160\u20137. doi: 10.5142/jgr.2010.34.3.160.", "ArticleIdList": ["10.5142/jgr.2010.34.3.160", "PMC3043615", "21359120"]}, {"Citation": "Cho IH. Effects of panax ginseng in neurodegenerative diseases. J Ginseng Res. 2012;36(4):342\u201353. doi: 10.5142/jgr.2012.36.4.342.", "ArticleIdList": ["10.5142/jgr.2012.36.4.342", "PMC3659610", "23717136"]}, {"Citation": "Hwang I, Ahn G, Park E, Ha D, Song JY, Jee Y. An acidic polysaccharide of panax ginseng ameliorates experimental autoimmune encephalomyelitis and induces regulatory T cells. Immunol Lett. 2011;138(2):169\u201378. doi: 10.1016/j.imlet.2011.04.005.", "ArticleIdList": ["10.1016/j.imlet.2011.04.005", "21524666"]}, {"Citation": "Etemadifar M, Sayahi F, Abtahi SH, Shemshaki H, Dorooshi GA, Goodarzi M. et al. Ginseng in the treatment of fatigue in multiple sclerosis: A randomized, placebo-controlled, double-blind pilot study. Int J Neurosci. 2013;123(7):480\u20136. doi: 10.3109/00207454.2013.764499.", "ArticleIdList": ["10.3109/00207454.2013.764499", "23301896"]}, {"Citation": "Siegel RK. Ginseng abuse syndrome. Problems with the panacea. JAMA. 1979;241(15):1614\u20135. doi: 10.1001/jama.1979.03290410046024.", "ArticleIdList": ["10.1001/jama.1979.03290410046024", "430716"]}, {"Citation": "Mertens M, Buettner A, Kirchhoff E. The volatile constituents of frankincense - a review. Flavour Fragrance J. 2009;24(6):279\u2013300. doi: 10.1002/ffj.1942.", "ArticleIdList": ["10.1002/ffj.1942"]}, {"Citation": "Tadesse W, Desalegn G, Alia R. Natural gum and resin bearing species of Ethiopia and their potential applications. Invest Agrar Sist Recur For. 2007;16(3):211\u201321. doi: 10.5424/srf/2007163-01010.", "ArticleIdList": ["10.5424/srf/2007163-01010"]}, {"Citation": "Mahmoudi A, Hosseini-Sharifabad A, Monsef-Esfahani HR, Yazdinejad AR, Khanavi M, Roghani A. et al. Evaluation of systemic administration of Boswellia papyrifera extracts on spatial memory retention in male rats. J Nat Med. 2011;65(3-4):519\u201325. doi: 10.1007/s11418-011-0533-y.", "ArticleIdList": ["10.1007/s11418-011-0533-y", "21479965"]}, {"Citation": "Banno N, Akihisa T, Yasukawa K, Tokuda H, Tabata K, Nakamura Y. et al. Anti-inflammatory activities of the triterpene acids from the resin of Boswellia carteri. J Ethnopharmacol. 2006;107(2):249\u201353. doi: 10.1016/j.jep.2006.03.006.", "ArticleIdList": ["10.1016/j.jep.2006.03.006", "16621377"]}, {"Citation": "Ammon HP. Modulation of the immune system by Boswellia serrata extracts and boswellic acids. Phytomedicine. 2010;17(11):862\u20137. doi: 10.1016/j.phymed.2010.03.003.", "ArticleIdList": ["10.1016/j.phymed.2010.03.003", "20696559"]}, {"Citation": "Omura Y, Horiuchi N, Jones MK, Lu DP, Shimotsuura Y, Duvvi H. et al. Temporary anti-cancer & anti-pain effects of mechanical stimulation of any one of 3 front teeth (1st incisor, 2nd incisor, & canine) of right & left side of upper & lower jaws and their possible mechanism, & relatively long term disappearance of pain & cancer parameters by one optimal dose of DHEA, Astragalus, Boswellia Serrata, often with press needle stimulation of True ST. 36. Acupunct Electrother Res. 2009;34(3-4):175\u2013203. doi: 10.3727/036012909803860997.", "ArticleIdList": ["10.3727/036012909803860997", "20344885"]}, {"Citation": "Langdon DW. Cognition in multiple sclerosis. Curr Opin Neurol. 2011;24(3):244\u20139. doi: 10.1097/WCO.0b013e328346a43b.", "ArticleIdList": ["10.1097/WCO.0b013e328346a43b", "21519256"]}, {"Citation": "Langdon DW, Amato MP, Boringa J, Brochet B, Foley F, Fredrikson S. et al. Recommendations for a brief international cognitive assessment for multiple sclerosis (BICAMS) Mult Scler. 2012;18(6):891\u20138. doi: 10.1177/1352458511431076.", "ArticleIdList": ["10.1177/1352458511431076", "PMC3546642", "22190573"]}, {"Citation": "Sedighi B, Pardakhty A, Kamali H, Shafiee K, Hasani BN. Effect of Boswellia papyrifera on cognitive impairment in multiple sclerosis. Iran J Neurol. 2014;13(3):149\u201353.", "ArticleIdList": ["PMC4240932", "25422734"]}, {"Citation": "Chiou A, Karathanos VT, Mylona A, Salta FN, Preventi F, Andrikopoulos NK. Currants (Vitis vinifera L.) content of simple phenolics and antioxidant activity. Food Chem. 2007;102(2):516\u201322. doi: 10.1016/j.foodchem.2006.06.009.", "ArticleIdList": ["10.1016/j.foodchem.2006.06.009"]}, {"Citation": "Fr\u00e9mont L. Biological effects of resveratrol. Life Sci. 2000;66(8):663\u201373. doi: 10.1016/S0024-3205(99)00410-5.", "ArticleIdList": ["10.1016/S0024-3205(99)00410-5", "10680575"]}, {"Citation": "Das S, Das DK. Anti-inflammatory responses of resveratrol. Inflamm\u00a0Allergy Drug\u00a0Targets. 2007;6(3):168\u201373. doi: 10.2174/187152807781696464.", "ArticleIdList": ["10.2174/187152807781696464", "17897053"]}, {"Citation": "de la Lastra CA, Villegas I. Resveratrol as an antioxidant and pro-oxidant agent: Mechanisms and clinical implications. Biochem Soc Trans. 2007;35(Pt 5):1156\u201360. doi: 10.1042/BST0351156.", "ArticleIdList": ["10.1042/BST0351156", "17956300"]}, {"Citation": "Sato F, Martinez NE, Shahid M, Rose JW, Carlson NG, Tsunoda I. Resveratrol exacerbates both autoimmune and viral models of multiple sclerosis. Am J Pathol. 2013;183(5):1390\u20136. doi: 10.1016/j.ajpath.2013.07.006.", "ArticleIdList": ["10.1016/j.ajpath.2013.07.006", "PMC3814682", "24091251"]}, {"Citation": "Fonseca-Kelly Z, Nassrallah M, Uribe J, Khan RS, Dine K, Dutt M. et al. Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis. Front Neurol. 2012;3:84. doi: 10.3389/fneur.2012.00084.", "ArticleIdList": ["10.3389/fneur.2012.00084", "PMC3359579", "22654783"]}, {"Citation": "Shindler KS, Ventura E, Dutt M, Elliott P, Fitzgerald DC, Rostami A. Oral resveratrol reduces neuronal damage in a model of multiple sclerosis. J Neuroophthalmol. 2010;30(4):328\u201339. doi: 10.1097/WNO.0b013e3181f7f833.", "ArticleIdList": ["10.1097/WNO.0b013e3181f7f833", "PMC3312784", "21107122"]}, {"Citation": "Bi XL, Yang JY, Dong YX, Wang JM, Cui YH, Ikeshima T. et al. Resveratrol inhibits nitric oxide and TNF-\u03b1 production by lipopolysaccharide-activated microglia. Int Immunopharmacol. 2005;5(1):185\u201393. doi: 10.1016/j.intimp.2004.08.008.", "ArticleIdList": ["10.1016/j.intimp.2004.08.008", "15589480"]}, {"Citation": "Meng XL, Yang JY, Chen GL, Wang LH, Zhang LJ, Wang S. et al. Effects of resveratrol and its derivatives on lipopolysaccharide-induced microglial activation and their structure-activity relationships. Chem Biol Interact. 2008;174(1):51\u20139. doi: 10.1016/j.cbi.2008.04.015.", "ArticleIdList": ["10.1016/j.cbi.2008.04.015", "18513711"]}, {"Citation": "Choi DK, Koppula S, Suk K. Inhibitors of microglial neurotoxicity: Focus on natural products. Molecules. 2011;16(2):1021\u201343. doi: 10.3390/molecules16021021.", "ArticleIdList": ["10.3390/molecules16021021", "PMC6259841", "21350391"]}, {"Citation": "Patel KR, Scott E, Brown VA, Gescher AJ, Steward WP, Brown K. Clinical trials of resveratrol. Ann N Y Acad Sci. 2011;1215(1):161\u20139. doi: 10.1111/j.1749-6632.2010.05853.x.", "ArticleIdList": ["10.1111/j.1749-6632.2010.05853.x", "21261655"]}, {"Citation": "Ahn EK, Jeon HJ, Lim EJ, Jung HJ, Park EH. Anti-inflammatory and anti-angiogenic activities of Gastrodia elata blume. J Ethnopharmacol. 2007;110(3):476\u201382. doi: 10.1016/j.jep.2006.10.006.", "ArticleIdList": ["10.1016/j.jep.2006.10.006", "17129693"]}, {"Citation": "Tsai CF, Huang CL, Lin YL, Lee YC, Yang YC, Huang NK. The neuroprotective effects of an extract of Gastrodia elata. J Ethnopharmacol. 2011;138(1):119\u201325. doi: 10.1016/j.jep.2011.08.064.", "ArticleIdList": ["10.1016/j.jep.2011.08.064", "21925258"]}, {"Citation": "Yu SJ, Kim JR, Lee CK, Han JE, Lee JH, Kim HS. et al. Gastrodia elata blume and an active component, p-hydroxybenzyl alcohol reduce focal ischemic brain injury through antioxidant related gene expressions. Biol Pharm Bull. 2005;28(6):1016\u201320. doi: 10.1248/bpb.28.1016.", "ArticleIdList": ["10.1248/bpb.28.1016", "15930737"]}, {"Citation": "Van Kampen J, Robertson H, Hagg T, Drobitch R. Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease. Exp Neurol. 2003;184(1):521\u20139. doi: 10.1016/j.expneurol.2003.08.002.", "ArticleIdList": ["10.1016/j.expneurol.2003.08.002", "14637121"]}, {"Citation": "Manavalan A, Ramachandran U, Sundaramurthi H, Mishra M, Sze SK, Hu JM. et al. Gastrodia elata Blume (tianma) mobilizes neuro-protective capacities. Int J Biochem Mol Biol. 2012;3(2):219\u201341.", "ArticleIdList": ["PMC3388733", "22773961"]}, {"Citation": "Kim BW, Koppula S, Kim JW, Lim HW, Hwang JW, Kim IS. et al. Modulation of LPS-stimulated neuroinflammation in BV-2 microglia by Gastrodia elata: 4-hydroxybenzyl alcohol is the bioactive candidate. J Ethnopharmacol. 2012;139(2):549\u201357. doi: 10.1016/j.jep.2011.11.048.", "ArticleIdList": ["10.1016/j.jep.2011.11.048", "22155394"]}, {"Citation": "Jung JW, Yoon BH, Oh HR, Ahn JH, Kim SY, Park SY. et al. Anxiolytic-like effects of Gastrodia elata and its phenolic constituents in mice. Biol Pharm Bull. 2006;29(2):261\u20135. doi: 10.1248/bpb.29.261.", "ArticleIdList": ["10.1248/bpb.29.261", "16462028"]}, {"Citation": "Hsieh CL, Chen CL, Tang NY, Chuang CM, Hsieh CT, Chiang SY. et al. Gastrodia elata BL mediates the suppression of nNOS and microglia activation to protect against neuronal damage in kainic acid-treated rats. Am J Chin Med. 2005;33(4):599\u2013611. doi: 10.1142/S0192415X0500320X.", "ArticleIdList": ["10.1142/S0192415X0500320X", "16173534"]}, {"Citation": "Wu HQ, Xie L, Jin XN, Ge Q, Jin H, Liu GQ. The effect of vanillin on the fully amygdala-kindled seizures in the rat. Yao Xue Xue Bao. 1989;24(7):482\u20136.", "ArticleIdList": ["2618688"]}, {"Citation": "Lee JY, Jang YW, Kang HS, Moon H, Sim SS, Kim CJ. Anti-inflammatory action of phenolic compounds from Gastrodia elata root. Arch Pharm Res. 2006;29(10):849\u201358. doi: 10.1007/BF02973905.", "ArticleIdList": ["10.1007/BF02973905", "17121179"]}, {"Citation": "Gramza-Michalowska A, Regula J. Use of tea extracts (Camelia sinensis) in jelly candies as polyphenols sources in human diet. Asia Pac J Clin Nutr. 2007;16(Suppl 1):43\u20136.", "ArticleIdList": ["17392075"]}, {"Citation": "Graham HN. Green tea composition, consumption, and polyphenol chemistry. Prev Med. 1992;21(3):334\u201350. doi: 10.1016/0091-7435(92)90041-F.", "ArticleIdList": ["10.1016/0091-7435(92)90041-F", "1614995"]}, {"Citation": "Chacko SM, Thambi PT, Kuttan R, Nishigaki I. Beneficial effects of green tea: A literature review. Chin Med. 2010;5:13. doi: 10.1186/1749-8546-5-13.", "ArticleIdList": ["10.1186/1749-8546-5-13", "PMC2855614", "20370896"]}, {"Citation": "Yang F, de Villiers WJ, McClain CJ, Varilek GW. Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. J Nutr. 1998;128(12):2334\u201340. doi: 10.1093/jn/128.12.2334.", "ArticleIdList": ["10.1093/jn/128.12.2334", "9868178"]}, {"Citation": "Koh SH, Lee SM, Kim HY, Lee KY, Lee YJ, Kim HT. et al. The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice. Neurosci Lett. 2006;395(2):103\u20137. doi: 10.1016/j.neulet.2005.10.056.", "ArticleIdList": ["10.1016/j.neulet.2005.10.056", "16356650"]}, {"Citation": "Neyestani TR, Gharavi A, Kalayi A. Selective effects of tea extract and its phenolic compounds on human peripheral blood mononuclear cell cytokine secretions. Int J Food Sci Nutr. 2009;60(Suppl 1):79\u201388. doi: 10.1080/09637480802158184.", "ArticleIdList": ["10.1080/09637480802158184", "18686109"]}, {"Citation": "Mandel SA, Avramovich-Tirosh Y, Reznichenko L, Zheng H, Weinreb O, Amit T. et al. Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway. Neurosignals. 2005;14(1-2):46\u201360. doi: 10.1159/000085385.", "ArticleIdList": ["10.1159/000085385", "15956814"]}, {"Citation": "Li R, Huang YG, Fang D, Le WD. (-)-Epigallocatechin gallate inhibits lipopolysaccharide-induced microglial activation and protects against inflammation-mediated dopaminergic neuronal injury. J Neurosci Res. 2004;78(5):723\u201331. doi: 10.1002/jnr.20315.", "ArticleIdList": ["10.1002/jnr.20315", "15478178"]}, {"Citation": "Molinari M, Watt KD, Kruszyna T, Nelson R, Walsh M, Huang WY. et al. Acute liver failure induced by green tea extracts: Case report and review of the literature. Liver Transpl. 2006;12(12):1892\u20135. doi: 10.1002/lt.21021.", "ArticleIdList": ["10.1002/lt.21021", "17133573"]}, {"Citation": "M\u00e4hler A, Steiniger J, Bock M, Klug L, Parreidt N, Lorenz M. et al. Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: A randomized clinical trial. Am J Clin Nutr. 2015;101(3):487\u201395. doi: 10.3945/ajcn.113.075309.", "ArticleIdList": ["10.3945/ajcn.113.075309", "25733633"]}, {"Citation": "Balch SA, McKenney CB, Auld DL. Evaluation of gamma-linolenic acid composition of evening primrose (Oenothera) species native to Texas. HortScience. 2003;38(4):595\u20138."}, {"Citation": "Horrobin DF. Nutritional and medical importance of gamma-linolenic acid. Prog Lipid Res. 1992;31(2):163\u201394. doi: 10.1016/0163-7827(92)90008-7.", "ArticleIdList": ["10.1016/0163-7827(92)90008-7", "1334266"]}, {"Citation": "Rezapour-Firouzi S, Arefhosseini SR, Mehdi F, Mehrangiz EM, Baradaran B, Sadeghihokmabad E. et al. Immunomodulatory and therapeutic effects of Hot-nature diet and co-supplemented hemp seed, evening primrose oils intervention in multiple sclerosis patients. Complement Ther Med. 2013;21(5):473\u201380. doi: 10.1016/j.ctim.2013.06.006.", "ArticleIdList": ["10.1016/j.ctim.2013.06.006", "24050582"]}, {"Citation": "Horrobin DF. Multiple sclerosis: The rational basis for treatment with colchicine and evening primrose oil. Med Hypotheses. 1979;5(3):365\u201378. doi: 10.1016/0306-9877(79)90018-5.", "ArticleIdList": ["10.1016/0306-9877(79)90018-5", "313499"]}, {"Citation": "Harbige LS, Sharief MK. Polyunsaturated fatty acids in the pathogenesis and treatment of multiple sclerosis. Br J Nutr. 2007;98(S1):S46\u201353. doi: 10.1017/S0007114507833010.", "ArticleIdList": ["10.1017/S0007114507833010", "17922959"]}, {"Citation": "Ahmadi A, Habibi G, Farrokhnia M. MS14, an iranian herbal-marine compound for the treatment of multiple sclerosis. Chin J Integr Med. 2010;16(3):270\u20131. doi: 10.1007/s11655-010-0270-1.", "ArticleIdList": ["10.1007/s11655-010-0270-1", "20694784"]}, {"Citation": "Naseri M, Ahmadi A, Gharegozli K, Nabavi M, Faghihzadeh S, Ashtarian N. et al. A double blind, placebo-controlled, crossover study on the effect of MS14, an herbal-marine drug, on quality of life in patients with multiple sclerosis. J Med Plant Res. 2009;3(4):271\u20135."}, {"Citation": "Tafreshi AP, Ahmadi A, Ghaffarpur M, Mostafavi H, Rezaeizadeh H, Minaie B. et al. An Iranian herbal-marine medicine, MS14, ameliorates experimental allergic encephalomyelitis. Phytother Res. 2008;22(8):1083\u20136. doi: 10.1002/ptr.2459.", "ArticleIdList": ["10.1002/ptr.2459", "18570265"]}, {"Citation": "Ebrahimi-Kalan A, Soleimani Rad J, Kafami L, Mohammadnejad D, Habibi Roudkenar M, Khaki AA. et al. MS14 down-regulates lipocalin2 expression in spinal cord tissue in an animal model of multiple sclerosis in female C57BL/6. Iran Biomed J. 2014;18(4):196\u2013202.", "ArticleIdList": ["PMC4225058", "25326017"]}, {"Citation": "Ebrahimi Kalan A, Soleimani Rad J, Kafami L, Mohamadnezhad D, Khaki AA, Mohammadi Roushandeh A. MS14, a marine herbal medicine, an immunosuppressive drug in experimental autoimmune encephalomyelitis. Iran Red Crescent Med J. 2014;16(7):e16956. doi: 10.5812/ircmj.16956.", "ArticleIdList": ["10.5812/ircmj.16956", "PMC4166093", "25237574"]}, {"Citation": "Kuddus M, Ginawi IAM, Al-Hazimi A. Cannabis sativa: An ancient wild edible plant of India. Emir J Food Agric. 2013;25(10):736\u201345. doi: 10.9755/ejfa.v25i10.16400.", "ArticleIdList": ["10.9755/ejfa.v25i10.16400"]}, {"Citation": "Saito VM, Rezende RM, Teixeira AL. Cannabinoid modulation of neuroinflammatory disorders. Curr Neuropharmacol. 2012;10(2):159\u201366. doi: 10.2174/157015912800604515.", "ArticleIdList": ["10.2174/157015912800604515", "PMC3386505", "23204985"]}, {"Citation": "Zajicek J, Fox P, Sanders H, Wright D, Vickery J, Nunn A. et al. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): Multicentre randomised placebo-controlled trial. Lancet. 2003;362(9395):1517\u201326. doi: 10.1016/S0140-6736(03)14738-1.", "ArticleIdList": ["10.1016/S0140-6736(03)14738-1", "14615106"]}, {"Citation": "Pertwee RG. Cannabinoids and multiple sclerosis. Pharmacol Ther. 2002;95(2):165\u201374. doi: 10.1016/S0163-7258(02)00255-3.", "ArticleIdList": ["10.1016/S0163-7258(02)00255-3", "12182963"]}, {"Citation": "Borgelt LM, Franson KL, Nussbaum AM, Wang GS. The pharmacologic and clinical effects of medical cannabis. Pharmacotherapy. 2013;33(2):195\u2013209. doi: 10.1002/phar.1187.", "ArticleIdList": ["10.1002/phar.1187", "23386598"]}, {"Citation": "Zajicek JP, Apostu VI. Role of cannabinoids in multiple sclerosis. CNS Drugs. 2011;25(3):187\u2013201. doi: 10.2165/11539000-000000000-00000.", "ArticleIdList": ["10.2165/11539000-000000000-00000", "21323391"]}, {"Citation": "Zajicek JP, Sanders HP, Wright DE, Vickery PJ, Ingram WM, Reilly SM. et al. Cannabinoids in multiple sclerosis (CAMS) study: Safety and efficacy data for 12 months follow up. J Neurol Neurosurg\u00a0Psychiatry. 2005;76(12):1664\u20139. doi: 10.1136/jnnp.2005.070136.", "ArticleIdList": ["10.1136/jnnp.2005.070136", "PMC1739436", "16291891"]}, {"Citation": "Zajicek J, Reif M, Schnelle M. Cannabis extract in the treatment of muscle stiffness and other symptoms in multiple sclerosis-Results of the MUSEC study. 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis. 2009."}, {"Citation": "Wade DT, Makela P, Robson P, House H, Bateman C. Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients. Mult Scler. 2004;10(4):434\u201341. doi: 10.1191/1352458504ms1082oa.", "ArticleIdList": ["10.1191/1352458504ms1082oa", "15327042"]}, {"Citation": "Grotenhermen F, M\u00fcller-Vahl K. The therapeutic potential of cannabis and cannabinoids. Dtsch Arztebl Int. 2012;109(29-30):495\u2013501. doi: 10.3238/arztebl.2012.0495.", "ArticleIdList": ["10.3238/arztebl.2012.0495", "PMC3442177", "23008748"]}, {"Citation": "Wirguin I, Mechoulam R, Breuer A, Schezen E, Weidenfeld J, Brenner T. Suppression of experimetal autoimmune encephalomyelitis by cannabinoids. Immunopharmacology. 1994;28(3):209\u201314. doi: 10.1016/0162-3109(94)90056-6.", "ArticleIdList": ["10.1016/0162-3109(94)90056-6", "7852052"]}, {"Citation": "Kmietowicz Z. Cannabis based drug is licensed for spasticity in patients with MS. BMJ. 2010;340:c3363. doi: 10.1136/bmj.c3363.", "ArticleIdList": ["10.1136/bmj.c3363", "20570870"]}, {"Citation": "Greenberg HS, Werness SA, Pugh JE, Andrus RO, Anderson DJ, Domino EF. Short-term effects of smoking marijuana on balance in patients with multiple sclerosis and normal volunteers. Clin Pharmacol Ther. 1994;55(3):324\u20138. doi: 10.1038/clpt.1994.33.", "ArticleIdList": ["10.1038/clpt.1994.33", "8143398"]}, {"Citation": "Brady CM, DasGupta R, Dalton C, Wiseman OJ, Berkley KJ, Fowler CJ. An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis. Mult Scler. 2004;10(4):425\u201333. doi: 10.1191/1352458504ms1063oa.", "ArticleIdList": ["10.1191/1352458504ms1063oa", "15327041"]}]}], "History": [{"Year": "2018", "Month": "5", "Day": "18"}, {"Year": "2018", "Month": "7", "Day": "30"}, {"Year": "2018", "Month": "8", "Day": "15"}, {"Year": "2019", "Month": "1", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "1", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "1", "Day": "5", "Hour": "6", "Minute": "1"}, {"Year": "2018", "Month": "11", "Day": "29"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30607330", "PMC6311642", "10.15171/apb.2018.066"]}}]}